These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9833270)

  • 1. [Introduction of general hepatitis B vaccination in Switzerland].
    Zimmermann H; Vaudaux B; Kammerlander R
    Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
    Zurn P; Danthine JP
    Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical recommendations for general introduction of hepatitis B vaccination].
    Vaudaux B; Wimmersberger A
    Soz Praventivmed; 1998; 43 Suppl 1():S69-71, S143-5. PubMed ID: 9833271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 5. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 6. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B vaccination: knowledge and acceptance by Swiss physicians].
    Gugelmann RJ; Freed GL; Desgrandchamps D; Diebold P
    Soz Praventivmed; 1998; 43 Suppl 1():S57-60, S130-3. PubMed ID: 9833268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
    Szucs TD; Smala A; Berger K; Windorfer A
    Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General hepatitis B vaccination in Switzerland: what is the attitude of vaccinating physicians?].
    Vaudaux B; Steinemann MA
    Soz Praventivmed; 1998; 43 Suppl 1():S47-56, S121-9. PubMed ID: 9833267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 12. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
    Nassauer KA
    Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.
    Van Damme P; Kane M; Meheus A
    BMJ; 1997 Apr; 314(7086):1033-6. PubMed ID: 9112852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 15. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
    Harris A; Yong K; Kermode M
    Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Information strategy for physicians and public health regarding introduction of general hepatitis B vaccination in Switzerland].
    Bourquin C; Zimmermann H
    Soz Praventivmed; 1998; 43 Suppl 1():S72-4, S146-8. PubMed ID: 9833272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.